Synthesis of Digital Microfluidic Biochips with Reconfigurable...

128
Synthesis of Digital Microfluidic Biochips with Reconfigurable Operation Execution Elena Maftei Technical University of Denmark DTU Informatics www.dreamstime.com

Transcript of Synthesis of Digital Microfluidic Biochips with Reconfigurable...

Page 1: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

Synthesis of Digital Microfluidic Biochips with Reconfigurable Operation Execution

Elena MafteiTechnical University of Denmark

DTU Informatics

www.dreamstime.com

Page 2: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

2Duke University

Digital Microfluidic Biochip

Page 3: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

3

Applications

Sampling and real time testing of air/water for biochemical toxins

Food testing DNA analysis and sequencing Clinical diagnosis Point of care devices Drug development

Page 4: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

4

Challenges: Design complexity Radically different design and test methods required Integration with microelectronic components in future SoCs

Advantages & Challenges

Advantages: High throughput (reduced sample / reagent consumption) Space (miniaturization) Time (parallelism) Automation (minimal human intervention)

Page 5: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

5

Outline

Motivation Architecture Operation Execution Contribution I

Module-Based Synthesis with Dynamic Virtual Devices Contribution II

Routing-Based Synthesis Contribution III

Droplet-Aware Module-Based Synthesis Conclusions & Future Directions

Page 6: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

6

Architecture and Working Principles

Biochip architecture Cell architecture

Electrowetting-on-dielectric

Droplet

Top plate

Ground electrode

Control electrodes

InsulatorsFiller fluid

Bottom plate

S2

R2

B

S3

S1 W

R1

Reservoir

Detector

Page 7: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

7

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging Storage Mixing/Dilution

Microfluidic Operations

Page 8: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

8

Reconfigurability

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging Storage Mixing/Dilution

Page 9: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

9

Reconfigurability

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging Storage Mixing/Dilution

Non-reconfigurable

Page 10: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

10

Reconfigurability

S2

R2

B

S3

S1 W

R1

Dispensing Detection

Splitting/Merging Storage Mixing/Dilution

Non-reconfigurable

Reconfigurable

Page 11: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

11

Module-Based Operation Execution

S2

R2

B

S3

S1 W

R1

2 x 4 module

Page 12: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

12

Module-Based Operation Execution

S2

R2

B

S3

S1 W

R1

Operation Area (cells) Time (s)

Mix 2 x 4 3

Mix 2 x 2 4

Dilution 2 x 4 4

Dilution 2 x 2 5

Module library

2 x 4 module

Page 13: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

13

Module-Based Operation Execution

S2

R2

B

S3

S1 W

R1

2 x 4 module

segregation cells

Page 14: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

14

Module-Based Operation Execution

S2

R2

B

S3

S1 W

R1

Operations confined to rectangular, fixed modules

Positions of droplets inside modules ignored

Segregation cells

Page 15: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

15

Module-Based Synthesis with Dynamic Virtual Modules

Page 16: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

16

Example

S1

S2

S3 B1

R2

R1

WB2

D1

tApplication graph

1 2

9

12

8

3 4

5 6

711

13

10

In S1 In B In S2 In R1

Dilute Mix

In S3 In B

Dilute

In BIn R2

Dilute

Page 17: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

17

Example

Biochip

S1

S2

S3 B1

R2

R1

WB2

D1

Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 18: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

18

Example

t

S1

S2

S3 B1

R2

R1

WB2

D1

D2(O5)

Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 19: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

19

Example

S1

S2

S3 B1

R2

R1

WB2

D3(O12)

M1(O6)

D4(O13)

store O5

t+4Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 20: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

20

Example

Application graph

S1

S2

S3 B1

R2

R1

WB2

D3(O12)

D4(O13)

M2(

O7)

t+8

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 21: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

21

Example

Schedule

Mixer1

Mixer2

Diluter2

Diluter3

Diluter4

O5

O6

O12

O13

O7

store

t t+8 t+11Allocation

Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 22: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

22

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

D1

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 23: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

23

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 24: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

24

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 25: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

25

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 26: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

26

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 27: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

27

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 28: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

28

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 29: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

29

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 30: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

30

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 31: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

31

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 32: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

32

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 33: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

33

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

D1

tApplication graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 34: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

34

Example

S1

S2

S3 B1

R2

R1

WB2

D2(O5)

D1

t

M1 (O6)

Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 35: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

35

Example

t+4

D3(O12)

S1

S2

S3 B1

R2

R1

WB2

M2

(O7)

D4(O13)

Application graph

2 x 22 x 2

2 x 4

2 x 22 x 4

S1

B1

S2 R1

R2 B2 B1 S3

1 2

9

12

8

3 4

5 6

711

13

10

Page 36: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

36

Example

Schedule – operation execution with dynamic virtual modules

O6Mixer1

Mixer2

Diluter2

Diluter3

Diluter4

O5

t t+9

O12

O13

O7

t+4AllocationMixer1

Mixer2

Diluter2

Diluter3

Diluter4

O5

O6

O12

O13

O7

store

t t+8 t+11Allocation

Schedule – operation execution with fixed virtual modules

Page 37: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

37

Solution

Tabu Search

List Scheduling

Maximal Empty Rectangles

Binding of modules to operations

Schedule of the operations Placement of modules performed inside scheduling

Placement of the modules Free space manager based on [Bazargan et al. 2000] that

divides free space on the chip into overlapping rectangles

Page 38: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

38

Dynamic Placement Algorithm

S1

S2

S3 B1

R1

R2

WB2

Rect2

Rec

t 1 Rec

t 3

(0,0) (7,0)

(0,4)

(3,8) (8,8)

D1

Page 39: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

39

Dynamic Placement Algorithm

S1

S2

S3 B1

R1

R2

WB2

D1

Rect2

Rec

t 1 Rec

t 3

(0,0)

D2(O5)

(6,4)

(3,4)

(8,8)

(7,0)

Page 40: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

40

Dynamic Placement Algorithm

Rect2

(4,0)

Rect1

(8,4)

(6,0)

S1

S2

S3 B1

R1

R2

WB2

D2(O5)

D1

(8,8)

Page 41: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

41

Experimental Evaluation

Tabu Search-based algorithm implemented in Java Benchmarks

Real-life applications Colorimetric protein assay In-vitro diagnosis Polymerase chain reaction – mixing stage

Synthetic benchmarks 10 TGFF-generated benchmarks with 10 to 100 operations

Comparison between: Module-based synthesis with fixed modules (MBS) T-Tree [Yuh et al. 2007] Module-based synthesis with dynamic modules (DMBS)

Page 42: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

42

Experimental EvaluationBest-, average schedule length and standard

deviation out of 50 runs for MBS

Area Time limit (min)

Best (s) Average (s) Standard dev. (%)

13 x 13 60 182 189.99 2.90

10 182 192.00 3.64

1 191 199.20 4.70

12 x 12 60 182 190.86 3.20

10 185 197.73 6.50

1 193 212.62 10.97

11 x 12 60 184 192.50 3.78

10 194 211.72 14.37

1 226 252.19 15.76

Colorimetric protein assayColorimetric protein assayColorimetric protein assayColorimetric protein assay

Page 43: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

43

Experimental Evaluation

Colorimetric protein assayColorimetric protein assay

Best schedule length out of 50 runs for MBS vs. T-Tree

10 x 10 10 x 9 9 x 90

50

100

150

200

250

300

MBST-Tree

Area (cells x cells)

Bes

t sch

edul

e le

ngth

(s)

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Colorimetric protein assayColorimetric protein assay22.91 % improvement for 9 x 9

Page 44: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

44

Experimental EvaluationAverage schedule length out of 50 runs for DMBS vs. MBS

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Colorimetric protein assayColorimetric protein assay7.68 % improvement for 11 x 12

13 x 13 12 x 12 11 x 120

50

100

150

200

250

DMBS MBS

Area (cells x cells)

Aver

age

sche

dule

leng

th (s

)

Page 45: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

45

Routing-Based Operation Execution

Page 46: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

46

Module-Based vs. Routing-Based Operation Execution

S2

R2

B

S3

S1 W

R1

S2

R2

B

S3

S1 W

R1

c2

c1

Page 47: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

47

Operation Execution Characterization

S2

R2

B

S3

S1 W

R1

c2

90◦90◦

0◦

180◦c1

p90, p180, p0 ?

Page 48: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

48

Operation Execution Characterization

Type Area (cells)

Time(s)

Mix/Dlt 2 x 4 2.9

Mix/Dlt 1 x 4 4.6

Mix/Dlt 2 x 3 6.1

Mix/Dlt 2 x 2 9.9

Input - 2

Detect 1 x 1 30

0◦ 0◦

0◦0◦ 90◦90◦

90◦

90◦

0◦

0◦ 90◦90◦

90◦

90◦

0◦180◦ 0◦

180◦0◦0◦

90◦ 90◦90◦

90◦

p90, p180, p0

Electrode pitch size = 1.5 mm, gap spacing = 0.3 mm, average velocity rate = 20 cm/s.

Page 49: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

49

Operation Execution Characterization

Type Area (cells)

Time(s)

Mix/Dlt 2 x 4 2.9

Mix/Dlt 1 x 4 4.6

Mix/Dlt 2 x 3 6.1

Mix/Dlt 2 x 2 9.9

Input - 2

Detect 1 x 1 30

p90 = 0.1 %

p180 = - 0.5 %

p0 = 0.29 %

p0 = 0.58 %

Electrode pitch size = 1.5 mm, gap spacing = 0.3 mm, average velocity rate = 20 cm/s.

1

2

Page 50: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

50

Example

1 2

7

10

4In S

1In R

1

Mix

Mix

In R2

3In S

2

8Mix

Dilute 9

5 6In S

3In B

11

13 Waste

In R1

12Mix

Application graph Biochip

S2

R2

B

R1

S1 W

S3

Page 51: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

51

Example

Application graph

1 2

7

10

43

8 9

5 6

11

1312

S2

R2

B

R1

S1 W

S3M

2(O

7)

M1(

O8)

t = 2.04 s

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 52: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

52

Example

t = 6.67 s

S2

R2

B

R1

S1 W

S3M

3(O

10)

D1(O

9)

Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 53: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

53

Example

t = 9.5 s

S2

R2

B

R1

S1 W

S3M

4(O

12)

M3(

O10

)Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 54: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

54

Example

Mixer1

Mixer3

Mixer2

O8

O9

2.04 12.506.67

O12

O10

Diluter1

Mixer4

O7

ScheduleApplication graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 55: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

55

Example

t = 2.03 s

S2

R2

R1

S1

B

W

83

4

4

4

9

6

6

6

5

1 1 1 227

Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 56: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

56

Example

t = 4.20 s

S2

R2

S1 W

S3

R1

B

13.58 times

7

8

9

Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 57: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

57

Example

t = 4.28 s

R2

WS1

R1

S3

B

S2

8

7

8

7

8810

7

7

7

e913 12e

13 13

13 13 131313 11

11

1111

Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 58: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

58

Example

t = 6.34 s

R2

WS1

R1

S3

B

S2

10.33 times

10

12

Application graph

1 2

7

10

43

8 9

5 6

11

1312

1 x 41 x 4 2 x 4

2 x 41 x 4 W

R1

R2 S

3 B S

2 R

1 S

1

Page 59: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

59

Example

Schedule – module-based operation execution

Schedule – routing-based operation execution

Mixer1

Mixer3

Mixer2

O8

O9

2.04 12.506.67

O12

O10

Diluter1

Mixer4

O7

2.03 6.354.20

O10

O7

O8

O9

O12

Page 60: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

60

Solution

1 2

7

10

4In S

1In R

1

Mix

Mix

In R2

Source

3In S

2

8Mix

Dilute

Sink

9

5 6In S

3In B

11

13 Waste

In R1

12Mix

Merge

Mix

Page 61: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

61

Solution

1 2

7

10

4In S

1In R

1

Mix

Mix

In R2

Source

3In S

2

8Mix

Dilute

Sink

9

5 6In S

3In B

11

13 Waste

In R1

12Mix

Merge

Mix Minimize the completiontime for the operation

Minimize the time until the droplets meet

Page 62: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

62

Solution

Greedy Randomized Adaptive Search Procedure (GRASP)

S2

R2

S3

R1

S1

B

W

3

3

3

2

1

Page 63: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

63

Solution

Greedy Randomized Adaptive Search Procedure (GRASP)

S2

R2

S3

R1

S1

B

W

3

3

3

2

1

For each droplet: Determine possible moves Evaluate each move

Merge: minimize Manhattan distance Mix: maximize operation execution

Make a list of the best N moves Perform a random move from N

Page 64: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

64

Solution

Greedy Randomized Adaptive Search Procedure (GRASP)

S2

R2

S3

R1

S1

B

W

3

3

3

2

1

For each droplet: Determine possible moves Evaluate each move

Merge: minimize Manhattan distance Mix: maximize operation execution

Make a list of the best N moves Perform a random move from N

Page 65: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

65

Solution

Greedy Randomized Adaptive Search Procedure (GRASP)

S2

R2

S3

R1

S1

B

W

3

3

3

2

1 1

For each droplet: Determine possible moves Evaluate each move

Merge: minimize Manhattan distance Mix: maximize operation execution

Make a list of the best N moves Perform a random move from N

Page 66: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

66

Solution

Greedy Randomized Adaptive Search Procedure (GRASP)

S2

R2

S3

R1

S1

B

W

3

3

3

2

1 1

3

For each droplet: Determine possible moves Evaluate each move

Merge: minimize Manhattan distance Mix: maximize operation execution

Make a list of the best N moves Perform a random move from N

Page 67: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

67

Experimental Evaluation

GRASP-based algorithm implemented in Java Benchmarks

Real-life applications Colorimetric protein assay

Synthetic benchmarks 10 TGFF-generated benchmarks with 10 to 100 operations

Comparison between: Routing-based synthesis (RBS) Module-based synthesis with fixed modules (MBS)

Page 68: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

68

Experimental Evaluation

Colorimetric protein assayColorimetric protein assay

44.95% improvement for 10 x 10

Colorimetric protein assayColorimetric protein assay

Average schedule length out of 50 runs for RBS vs. MBS

Colorimetric protein assay

11 x 11 11 x 10 10 x 10 0

50

100

150

200

250

RBSMBS

Area (cells x cells)

Aver

age

sche

dule

leng

th (s

)Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Colorimetric protein assayColorimetric protein assay44.95 % improvement for 10 x 10

Page 69: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

69

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

Page 70: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

70

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

W

S3 B1

B2

S2

R3

R2

1

residues

Page 71: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

71

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Page 72: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

72

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Page 73: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

73

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Page 74: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

74

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Partition1

Partition2 w2

Page 75: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

75

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Partition1

Partition2 w2

S1

R1

S3 B1

B2

S2

R2

1

WR3

Page 76: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

76

Routing-Based Operation Execution - Conclusions

Improved completion time compared to module-based synthesis

Challenge: contamination

S1

R1

S3 B1

B2

S2

R2

WR3

1

w1

Partition1

Partition2 w2

S1

R1

S3 B1

B2

S2

R2

1

WR3

w2

w1

Page 77: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

77

Droplet-Aware Operation Executionwithout Contamination

Page 78: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

78

Example

Biochip

1 2

9

12

In S1 In B

8In S3

3 4 In R1

5 6

7In B 11

13

10In R2

Dilute Dilute

MixDilute

In S2

MixIn B

Application graph

S1

R2

W

S3 B1

S2

R1

B2

Page 79: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

79

Example

S1

R2

W

S3 B1

S2

R1

B2

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

Application graph Biochip

B1

R1

Page 80: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

80

Example

S1

R2

W

S3 B1

S2

R1

B2

M1(O6)

D1(O5)

t = 2 sApplication graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 81: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

81

Example

t = 4.9 s

D3(O13)

D2(O12)M2 (

O7)

S1

R2

W

S3 B1

S2

R1

B2

Application graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 82: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

82

Example

Diluter1O5

O12

2 114.9

O7

O6

O13

Diluter2

Diluter3

Mixer1

Mixer2

ScheduleApplication graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 83: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

83

Example

S1

R2

W

S3 B1

S2

R1

B2

M1(O6)

D1(O5)

t = 2 sApplication graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 84: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

84

Example

t = 2 s

S1

R2

W

S3 B1

S2

R1

B2

M1(O6)D1(O5)

65

Application graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 85: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

85

Example

t = 4.17 s

S1

R2

W

S3 B1

S2

R1

B2

D3(O13)

M2(O7)D2(O12)

7 12

13

Application graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 86: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

86

Example

Schedule

Diluter1O5

O12

2 4.17

O7

O6

O13

Diluter2

Diluter3

Mixer1

Mixer2

6.67

Application graph

1 2

9

12

In S1

8In S3

3 4 In R1

5 6

711

13

10

Dilute Dilute

MixDilute

In S2

Mix

2 x 42 x 4

1 x 4

R2

B2

2 x 32 x 3

S3

B1

S1

S2

B1

R1

Page 87: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

87

Example

Schedule – module-based operation execution

Schedule – droplet-aware operation execution

Diluter1O5

O12

2 4.17

O7

O6

O13

Diluter2

Diluter3

Mixer1

Mixer2

6.67

Diluter1O5

O12

2 114.9

O7

O6

O13

Diluter2

Diluter3

Mixer1

Mixer2

Page 88: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

88

Solution

Location of modules determined using Tabu Search Greedy movement of droplets inside modules Routing of droplets between modules and between

modules and I/O ports determined using GRASP

Page 89: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

89

Droplet-Aware Operation Execution

S1

R2

W

S3 B1

S2

B2

R1

M2(O7)

D3(O13)

D2(O12)

Page 90: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

90

Droplet-Aware Operation Execution

S1

R2

W

S3 B1

S2

B2

R1

13 13 13 13

12

12

12 12

777

7

Page 91: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

91

Droplet-Aware Operation Execution

S1

R2

W

S3 B1

S2

B2

R1

13 13 13 13

12

12

12 12

777

7

Page 92: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

92

Droplet-Aware Operation Execution

S1

R2

W

S3 B1

S2

B2

R1

13 13 13 13

12

12

12 12

7

777

7

Page 93: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

93

Experimental Evaluation

Algorithm implemented in Java Benchmarks

Real-life applications In-vitro diagnosis Colorimetric protein assay

Synthetic benchmarks 3 TGFF-generated benchmarks with 20, 40, 60 operations

Comparison between: Droplet-aware module-based synthesis (DAS) Module-based synthesis (MBS)

Page 94: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

94

Experimental Evaluation

21.55% improvement for 13 x 13

Colorimetric protein assayColorimetric protein assayColorimetric protein assayColorimetric protein assay

Average schedule length out of 50 runs for DAS vs. MBS

Colorimetric protein assayColorimetric protein assay

15 x 15 14 x 14 13 x 130

20

40

60

80

100

120

140

DASMBS

Area (cells x cells)

Aver

age

sche

dule

leng

th (s

)

Colorimetric protein assayColorimetric protein assay21.55 % improvement for 13 x 13

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Page 95: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

95

Experimental Evaluation

Algorithm implemented in Java Benchmarks

Real-life applications Colorimetric protein assay

Synthetic benchmarks 3 TGFF-generated benchmarks with 20, 40, 60 operations

Comparison between: Droplet-aware module-based synthesis (DASC) Routing-based synthesis (RBSC)

with contamination avoidance

Page 96: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

96

Experimental Evaluation

11.19% improvement for 14 x 14

Colorimetric protein assayColorimetric protein assay

Average schedule length out of 50 runs for DASC vs. RBSC

15 x 15 14 x 14 13 x 13 0

50

100

150

200

250

DASCRBSC

Area (cells x cells)

Aver

age

sche

dule

leng

th (s

)

Colorimetric protein assayColorimetric protein assay11.19 % improvement for 14 x 14

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Page 97: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

97

Contributions

Tabu Search-based algorithm for the module-based synthesis with fixed devices [CASES09]

Module-based synthesis with virtual devices [CASES09] Module-based synthesis with non-rectangular virtual

devices [DAEM10] Analytical method for operation execution characterization

[CASES10] Routing-based synthesis [CASES10] + contamination

[DAEM, submitted] Droplet-aware module based synthesis [JETC, submitted] ILP formulation for the synthesis of digital biochips [VLSI-

SoC08]

Page 98: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

98

Conclusions

Proposed several synthesis techniques for DMBs Considered the reconfigurability characteristic of DMBs Shown that by considering reconfigurability during operation execution improvements in the completion time of applications can be obtained

Page 99: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

99

Future Directions

S1

R2

W

S3 B1

S2

R1

B2

M1

M2

Page 100: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

100

Future Directions

S1

R2

W

S3 B1

S2

R1

B2

M1

M2

M1

M2

S1

R2

W

S3 B1

S2

R1

B2

Module-Based Synthesis with Overlapping Devices

Page 101: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

101

Future Directions

S1

R2

W

S3 B1

S2

R1

B2

Fault-Tolerant Module-Based Synthesis

M1(O1)

M2(O2) Faulty cellS1

R2

W

S3 B1

S2

R1

B2

M1(O1)

M2(O2)

M3(

O3)

Page 102: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

102

Future Directions

S1

R2

W

S3 B1

S2

R1

B2

Fault-Tolerant Module-Based Synthesis

Faulty cellS1

R2

W

S3 B1

S2

R1

B2

M1(O1)

M2(O2)

M3(

O3)

M2(O2)

M1(O1) M

3(O

3)

Page 103: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

103

Page 104: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

104

Back-up slides

Page 105: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

105

Electrowetting

Page 106: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

106

Surface Tension

Imbalance of forces between moleculesat an interface (gas/liquid, liquid/liquid,gas/solid, liquid/solid)

Page 107: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

107

Dispensing

Page 108: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

108

Dispensing

Page 109: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

109

Dispensing

Page 110: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

110

Splitting

Page 111: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

111

Mixing

Page 112: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

112

Capacitive sensor

Page 113: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

113

Design Tasks

Operation Area(cells) Time(s)Mix 2 x 2 10 Mix 1 x 3 5

Dilute 1 x 3 8Dilute 2 x 5 3

Page 114: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

114

Design Tasks

Operation Area(cells) Time(s)Mix 2 x 2 10 Mix 1 x 3 5

Dilute 1 x 3 8Dilute 2 x 5 3

S1

S2

S3 B

R1

R2

Page 115: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

115

Experimental EvaluationQuality of the solution compared to classical operation execution

Best out of 50

Colorimetric protein assayColorimetric protein assay9.73% improvement for 11 x 12

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

13 x 13 12 x 12 11 x 120

50

100

150

200

250

DMBS vs. FMBS

DMBS FMBS

Area (cells x cells)

Bes

t sch

edul

e le

ngth

(s)

Page 116: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

116

Experimental EvaluationQuality of the solution compared to classical operation execution

Best out of 50

11 x 11 11 x 10 10 x 10 0

50

100

150

200

250

RBS vs. MBS

RBSMBS

Area (cells x cells)

Bes

t sch

edul

e le

ngth

(s)

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Colorimetric protein assayColorimetric protein assay44.63% improvement for 10 x 10

Page 117: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

117

Experimental EvaluationQuality of the solution compared to classical operation execution

Best out of 50

Colorimetric protein assayColorimetric protein assayColorimetric protein assay

Colorimetric protein assayColorimetric protein assay15.76% improvement for 13 x 13

15 x 15 14 x 14 13 x 130

20

40

60

80

100

120

140

DAS vs. MBS

DASMBS

Area (cells x cells)

Bes

t sch

edul

e le

ngth

(s)

Page 118: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

118

Future Directions

S1

R2

W

S3 B1

S2

B2

R1

3

2

1

Pin-Constrained Routing-Based Synthesis

Page 119: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

119

Future Directions

S1

R2

W

S3 B1

S2

B2

R1

3

2

1

Pin-Constrained Routing-Based Synthesis

Page 120: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

120

Future Directions

S1

R2

W

S3 B1

S2

B2

R1

3

2

1

Pin-Constrained Routing-Based Synthesis

Page 121: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

121

Microfluidic Operations

S2

R2

B

S3

S1 W

R1

Dispensing

Dispensing

Page 122: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

122

Microfluidic Operations

S2

R2

B

S3

S1 W

R1

Dispensing Detection

Page 123: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

123

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging

Microfluidic Operations

Page 124: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

124

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging

Microfluidic Operations

Page 125: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

125

S2

R2

B

S3

S1 W

R1

Dispensing Detection Splitting/Merging Storage

Microfluidic Operations

Page 126: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

126

Motivational Example (for the first contrib)

Application graph

Operation Area(cells) Time(s)Mix 2 x 4 3Mix 2 x 2 4

Dilution 2 x 4 4Dilution 2 x 2 5

Dispense - 2

Module library

1 2

9

12

In S1 In B

8In S3

3 4 In R1

5 6

7In B 11

13

10In R2

Dilute Dilute

MixDilute

In S2

MixIn B

Page 127: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

127

Motivational Example(for the 2nd contrib)

1 2

7

10

4In S

1In R

1

Mix

Mix

In R2

Source

3In S

2

8Mix

Dilute

Sink

9

5 6In S

3In B

11

13 Waste

In R1

12Mix

Application graph

Type Area (cells)

Time(s)

Mix/Dlt 2 x 4 2.9Mix/Dlt 1 x 4 4.6Mix/Dlt 2 x 3 6.1Mix/Dlt 2 x 2 9.9Input - 2Detect 1 x 1 30

Module library

Page 128: Synthesis of Digital Microfluidic Biochips with Reconfigurable ...paupo/publications/Maftei2011aa-Synthesis...DNA analysis and sequencing Clinical diagnosis Point of care devices Drug

128

Example(for the 3rd contrib)

Type Area (cells)

Time(s)

Mix/Dlt 2 x 4 2.9Mix/Dlt 1 x 4 4.6Mix/Dlt 2 x 3 6.1Mix/Dlt 2 x 2 9.9Input - 2Detect 1 x 1 30

Module libraryApplication graph

1 2

9

12

In S1 In B

8In S3

3 4 In R1

5 6

7In B 11

13

10In R2

Dilute Dilute

MixDilute

In S2

MixIn B